AtriCure, Inc. (ATRC) is a surgical & medical instruments & apparatus company. Piotroski F-Score 8/9. 15 insider Form 4 filings in the last 90 days. Next earnings projected around 2026-07-28 from ATRC's year-over-year reporting pattern (not yet company-confirmed). Fundamentals from SEC filings; prices are end-of-day.
EOD daily bars · delayed, not real-time · data: DatabentoCharting by TradingView Lightweight Charts™
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
FY ending 2025-12-31 vs 2024-12-31. original 1968 formula; calibrated on manufacturers, read financials/REITs with care
A plain-English read on ATRC plus an auto-SWOT — built from ATRC's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate ATRC using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
| Prange KarenDirector | SELL | $86K | view → |
| Doraiswamy VinayakChief Scientific Officer | SELL | $141K | view → |
| Doraiswamy VinayakChief Scientific Officer | SELL | $149K | view → |
Projected from ATRC's own SEC 8-K filing history — the year-over-year reporting pattern (~50% land the exact day, ~90% within a week). No analyst estimates, no scraped calendars, nothing invented. It upgrades to a confirmed date + time the moment ATRC files its announcement.
ATRC has sold off after 6 of its last 8 earnings reports.
Large earnings reactions have been common.
ATRC has traded lower after most recent earnings releases.
The average is inflated by its most volatile prints (+10.4% and -12.2%).
A more typical earnings reaction has been approximately ±6.1%.
Realized close-to-close history only — no options-implied move, no analyst estimates.
| Reported | Close-to-close |
|---|---|
| 2026-05-05 | -2.7% |
| 2026-02-17 | -1.2% |
| 2026-01-12 | -12.2% |
| 2025-10-29 | -6.5% |
| 2025-07-29 | +5.7% |
| 2025-04-29 | -11.2% |
| 2025-02-12 |
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
| -4.6% |
| 2025-01-13 | +10.4% |